BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6324650)

  • 1. Characterization of phorbol esters binding to K 562 cells.
    Louache F; Villeval JL; Pelicci PG; Rouis M; Titeux M; Henri A; Rochant H; Thomopoulos P; Testa U
    Anticancer Res; 1984; 4(1-2):33-9. PubMed ID: 6324650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between human and goose erythrocytes in response to phorbol esters and expression of phorbol ester receptors.
    Speizer LA; Atherton SE; Sando JJ
    Cancer Res; 1987 Sep; 47(18):4830-4. PubMed ID: 3476197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phorbol ester binding to chemotactically responding and nonresponding Walker 256 carcinosarcoma cells.
    Clarke PR; Varani J
    Cancer Res; 1984 Nov; 44(11):4967-71. PubMed ID: 6593115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of phorbol ester receptor down modulation in human myeloblastic leukemia ML-1 cells by differentiation-stimulating serum components.
    Sakagami H; Hromchak R; Block A
    Cancer Res; 1984 Aug; 44(8):3330-5. PubMed ID: 6331642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor promoter receptors regulating neurite formation in cultured human neuroblastoma cells.
    Spinelli W; Ishii DN
    Cancer Res; 1983 Sep; 43(9):4119-25. PubMed ID: 6307504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of phorbol ester receptors in the 12-0-tetradecanoyl-phorbol-13-acetate (TPA)-induced down-regulation of colony-stimulating factor (CSF-1) binding to murine peritoneal exudate macrophages.
    Chen BD; Wilkins KL
    J Cell Physiol; 1985 Aug; 124(2):305-12. PubMed ID: 3876342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the growth inhibition induced by tumor-promoting phorbol esters and of their receptor binding in A549 human lung carcinoma cells.
    Gescher A; Reed DJ
    Cancer Res; 1985 Sep; 45(9):4315-21. PubMed ID: 3861245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukemia cell lines with comparable receptor binding characteristics but different phenotypic responses to phorbol diesters.
    Weinberg JB; Misukonis MA; Goodwin BJ
    Cancer Res; 1984 Mar; 44(3):976-80. PubMed ID: 6318990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of in vitro differentiation on phorbol diester receptor number in human promyelocytic leukemia (HL-60) cells.
    Lane RW; Sturm RJ; Borzelleca JF; Carchman RA
    Cancer Res; 1986 Aug; 46(8):3782-8. PubMed ID: 3460690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific binding of phorbol ester tumor promoters to intact primary epidermal cells from Sencar mice.
    Solanki V; Slaga TJ
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2549-53. PubMed ID: 6941309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down regulation of specific binding of [20-3H]phorbol 12,13-dibutyrate and phorbol ester-induced differentiation of human promyelocytic leukemia cells.
    Solanki V; Slaga TJ; Callaham M; Huberman E
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1722-5. PubMed ID: 6940185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homologous and heterologous mitogenic desensitization of Swiss 3T3 cells to phorbol esters and vasopressin: role of receptor and postreceptor steps.
    Collins MK; Rozengurt E
    J Cell Physiol; 1984 Feb; 118(2):133-42. PubMed ID: 6319436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cellular phospholipid modification on phorbol diester binding.
    Cabot MC
    Cancer Res; 1983 Sep; 43(9):4233-8. PubMed ID: 6307508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of phorbol dibutyrate and epidermal growth factor to cultured human epidermal cells.
    Greenebaum E; Nicolaides M; Eisinger M; Vogel RH; Weinstein IB
    J Natl Cancer Inst; 1983 Mar; 70(3):435-41. PubMed ID: 6300498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient modulation and internalization of T4 antigen induced by phorbol esters.
    Hoxie JA; Matthews DM; Callahan KJ; Cassel DL; Cooper RA
    J Immunol; 1986 Aug; 137(4):1194-201. PubMed ID: 3090141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of phorbol ester receptors and their down-modulation in GH4C1 rat pituitary cells.
    Jaken S; Tashjian AH; Blumberg PM
    Cancer Res; 1981 Jun; 41(6):2175-81. PubMed ID: 6786733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of [3H]phorbol-12,13-dibutyrate binding sites in mouse neuroblastoma cells: simultaneous down-regulation by phorbol esters and desensitization of their inhibition of muscarinic receptor function.
    Lai WS; el-Fakahany EE
    J Pharmacol Exp Ther; 1988 Jan; 244(1):41-50. PubMed ID: 3422096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonist of phorbol ester receptor-mediated chemotaxis in mouse peritoneal macrophages.
    Sturm RJ; Smith BM; Lane RW; Laskin DL; Harris LS; Carchman RA
    Cancer Res; 1983 Oct; 43(10):4552-6. PubMed ID: 6309370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phorbol ester-binding inhibitory factor from human placenta. Partial purification, characterization and biological effects.
    Hamel E; Yamasaki H; Tayot JL
    IARC Sci Publ; 1984; (56):157-64. PubMed ID: 6598799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific binding of [3H]phorbol dibutyrate to phorbol diester-responsive and -resistant clones of a human myeloid leukemia (KG-1) line 1.
    Lehrer RI; Cohen LE; Koeffler HP
    Cancer Res; 1983 Aug; 43(8):3563-6. PubMed ID: 6574815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.